The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 2 study of camrelizumab (anti-PD-1 antibody) combined with apatinib and chemotherapy for the first-line treatment of advanced esophageal squamous cell carcinoma.
 
Bo Zhang
No Relationships to Disclose
 
Ling Qi
No Relationships to Disclose
 
Xi Wang
No Relationships to Disclose
 
Jun Jiang
No Relationships to Disclose
 
Xin Zhang
No Relationships to Disclose
 
Yun Liu
No Relationships to Disclose
 
Lan Mu
No Relationships to Disclose
 
Jing Huang
No Relationships to Disclose